Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-24 @ 6:36 PM
NCT ID:
NCT01958957
Eligibility Criteria:
Inclusion Criteria:
* patients according to diagnostic standards on western medical ischemic stroke;
* patients according to diagnostic standards on Chinese medical attack to meridians;
* patients according to differentiation standards on syndrome of intermingled phlegm and blood stasis;
* 2 weeks to 6 months after attack;
* Age between 18-80 years;
* patients must volunteer to participate in this study and sign the informed consent form.
Exclusion Criteria:
* patients accompanying unconsciousness or severe dementia;
* ALT, AST≥2 times of upper limit of normal;
* patients with other severe diseases such as disease in circulatory system, hematopoietic system, digestive system, endocrine system etc;
* patients allergic to Ginkgo biloba drugs，Meglumine and meglumine agents;
* patients who are pregnant, lactating or planning for pregnancy;
* patients with insanity;
* patients who are not suitable for clinical trial under doctors' consideration;
* patients with Merge bleeding after infarction or patients with hemorrhagic tendency;
* patients with lower extremity venous thrombosis;
* patients who have participated in other clinical trial within 1 month.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01958957
Study Brief:
Protocol Section:
NCT01958957